Skip to main content
Market intelligence
TENXHealthcare

Tenax Therapeutics Inc insider activity

In the last 90 days, 5 corporate insiders purchased $12,659,836 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
2
90-day purchase value
$12,659,836
Corporate buyers
5
Latest transaction
Oct 21, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 21, 2026Daniel SchneebergerCorporate insiderOpen Market Purchase922,849$1.59$1,463,454
Oct 21, 2026Adar1 Capital Management LlcCorporate insiderOpen Market Purchase922,849$1.59$1,463,454
Sep 16, 2026Declan DooganDirectorOpen Market Purchase53,000$1.92$101,760